Isotope Lab Wants Bulk Controlled Substance Production
Published Date: 9/12/2025
Notice
Summary
Cambridge Isotope Laboratories, Inc. wants to get official approval to make large amounts of certain controlled substances. This means they can legally produce these drugs in bulk, which could speed up research and medical uses. If approved, this change affects researchers and healthcare providers who rely on these substances, with no immediate cost changes announced.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Company Seeks Bulk Drug Manufacturing Approval
Cambridge Isotope Laboratories, Inc. applied to be registered as a bulk manufacturer of certain controlled substances so it can legally produce large amounts of those drugs. If approved, this could speed up research and medical uses and would affect researchers and healthcare providers who rely on these substances; the notice says there are no immediate cost changes announced.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in